Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

TRAILBLAZER-ALZ trial data reveal that modified donanemab dosing reduces ARIA risk in early Alzheimer’s disease, with ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis ...

The AI tool, called MindGlide, developed by researchers from the University College London (UCL) uses mathematical models to ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.

The authors report a rare case of retinal pigment epithelial (RPE) adenoma in a child who presented with blurred vision in the right eye for 5 years. Examination revealed visual acuity of light ...